Pharmafile Logo

Engaging doctors around the globe

March 21, 2022 |  

Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies are now exploring and exploiting a myriad of different digital channels in order to deliver content to, and engage with, their target audiences.

According to a recent global survey analysis by Indegene, the average allocation to digital channels from overall pharmaceutical marketing budgets in 2020 has doubled since 2016, to 34%. Over a third of companies reported they foresee an increase in their digital budget allocation to more than 50% over the next 3 years. Given the global impact of the COVID-19 pandemic, it is fair to assume that efforts to enhance digital capabilities will accelerate more quickly than originally expected. However, it is not only the value of digital spend that is changing, but the focus of that expenditure and the sophistication of methods being adopted. Across global campaigns, for example, pharmaceutical marketers are recognising the necessity to create customised content; the 2020 Indegene report found that 74% use personalising content and 60% use localising content as effective content strategies.

Digitally engaging doctors around the world nevertheless remains a challenge. A report from McKinsey concluded that while most pharmaceutical companies are building digital capabilities, efforts are often disjointed, being spread across multiple small projects, with a lack of cohesion of resource. In the absence of clear strategy and support from senior levels, obtaining sufficient funding and resource can be a hurdle. A need to acquire appropriate talent and form effective partnerships is widely acknowledged, however identifying the correct partnerships and ensuring maximum benefit is achieved can be challenging.

This whitepaper explores the common challenges encountered when planning and delivering a global digital marketing campaign within the pharmaceutical arena. The impacts of local knowledge, establishing and utilising trusted relationships with HCPs and a global-to-local approach are examined

To read the full report please click here.

This content was provided by M3 (EU)

Company Details

 Latest Content from  M3 (EU) 

Tailored and Targeted Pharmaceutical Marketing

Learn more about targeted personas for HCP marketing.    If pharma companies want to differentiate themselves against their competition and produce impactful results they must be much bolder than the current state...

Learning to invest in doctors’ education

Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for...

Engaging doctors around the globe

Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies...

How do doctors spend their time online?

In our recent research piece, Doctor networks: The rules of engagement for pharma, some overarching principles for online engagement between the pharmaceutical industry and doctors were defined.

How do doctors want to engage with pharma on new products?

More than 80% of European doctors agree they are interested in staying up-to-date with new developments about pharmaceutical products. But what influences their choice of treatment and how do they...

M3 Acquires MirVracha LCC in Russia Launching Full-Scale Development of Physician Platform Business in Russia

M3, Inc. (Headquarters: Tokyo, Japan; CEO: Itaru Tanimura; URL: https://corporate.m3.com/; “M3” below) has announced the acquisition of MirVracha LCC (Headquarters: Moscow, Russia; CEO: Shotaro Yamamoto; “MirVracha” below), a website provider...

Revolutionising the Digital Content Delivery Model

Pharmaceutical industry processes don’t have to make the delivery of marketing campaigns slow and unmanageable, and thus ineffective. Changing working practices and really, truly thinking differently about how to deliver...

Healthcare in the Digital Age

Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.

M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group

M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs...

UK's department of Health deploys information campaign to ensure continued vigilance over Ebola

The threat of Ebola being transmitted within the UK may be low but frontline health workers must remain vigilant nevertheless. This is the message being communicated by the Department of...